Skip to main content
. 2019 Jun 26;40(20):2706–2717. doi: 10.1002/elps.201900167

Table 7.

Result of mathematical modeling predictions for currently published LAMP experiments

Reference DNA type Gel type Predicted sizes (bp) Structure sizes (bp)
Notomi 5 M13mp18 2% agarose gel and followed by SYBR Green I stain
  • x = 1: 261

  • x = 2: 422

  • x = 3: 584

  • x = 4: 745

  • x = 5: 907

  • x = 6: 1068

  • x = 1: ∼270

  • x = 2: ∼440

  • x = 3: ∼600

  • x = 4: ∼800

  • (Fig. 3A , Lane 4) 5

Iwamoto 7 Genomic DNA from Mycobacterium tuberculosis 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 157

  • x = 2: 249

  • x = 3: 342

  • x = 4: 434

  • x = 5: 527

  • x = 6: 619

  • x = 1: ∼150

  • x = 2: ∼250

  • x = 3: ∼350

  • x = 4: ∼450

  • (Fig. 2 Lane 1) 7

Iwamoto 7 Genomic DNA from Mycobacterium avium ATCC 25291 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 174

  • x = 2: 273

  • x = 3: 375

  • x = 4: 474

  • x = 5: 576

  • x = 6: 675

  • x = 1: ∼165

  • x = 2: ∼285

  • x = 3: ∼390

  • x = 4: ∼490

  • (Fig. 2 Lane 6) 7

Iwamoto 7 Genomic DNA from Mycobacterium intracellular ATCC 13950 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 180

  • x = 2: 300

  • x = 3: 411

  • x = 4: 531

  • x = 5: 642

  • x = 6: 762

  • x = 1: ∼180

  • x = 2: ∼275

  • x = 3: ∼395

  • x = 4: ∼500

  • (Fig. 2 Lane 11) 7

Thai 18 Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV) 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 168

  • x = 2: 277

  • x = 3: 364

  • x = 4: 473

  • x = 5: 560

  • x = 6: 669

  • x = 1: ∼175

  • x = 2: ∼280

  • x = 3: ∼380

  • x = 4: ∼490

  • (Fig. 2 Lane 2) 18

Dukes 19 RT‐LAMP of Foot and Mouth Disease Virus Strain O UKG 35/2001 Agarose gel with Picogreen®
  • x = 1: 154

  • x = 2: 252

  • x = 3: 340

  • x = 4: 438

  • x = 5: 526

  • x = 6: 624

  • x = 1: ∼150

  • x = 2: ∼240

  • x = 3: ∼350

  • x = 4: ∼450

  • (Fig. 3 Lane 1) 19

Han 20 Plasmodium genus 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 162

  • x = 2: 255

  • x = 3: 348

  • x = 4: 441

  • x = 5: 534

  • x = 6: 627

  • x = 1: ∼155

  • x = 2: ∼250

  • x = 3: ∼340

  • x = 4: ∼430

  • (Fig. 3 Lane 1) 20

Han 20 P. falciparum 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 165

  • x = 2: 275

  • x = 3: 374

  • x = 4: 484

  • x = 5: 583

  • x = 6: 693

  • x = 1: ∼ 160

  • x = 2: ∼ 270

  • x = 3: ∼ 370

  • x = 4: ∼ 480

  • (Fig. 3 Lane 3) 20

Han 20 P. vivax 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 165

  • x = 2: 269

  • x = 3: 364

  • x = 4: 468

  • x = 5: 563

  • x = 6: 667

  • x = 1: ∼ 160

  • x = 2: ∼ 260

  • x = 3: ∼ 350

  • x = 4: ∼ 450

  • (Fig. 3 Lane 5) 20

Han 20 P. malariae 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 195

  • x = 2: 307

  • x = 3: 422

  • x = 4: 534

  • x = 5: 649

  • x = 6: 761

  • x = 1: ∼ 200

  • x = 2: ∼ 310

  • x = 3: ∼ 420

  • x = 4: ∼ 530

  • (Fig. 3 Lane 7) 20

Han 20 P. ovale 3% agarose gel and followed by ethidium bromide stain
  • x = 1: 183

  • x = 2: 304

  • x = 3: 404

  • x = 4: 525

  • x = 5: 625

  • x = 6: 746

  • x = 1: ∼ 175

  • x = 2: ∼ 290

  • x = 3: ∼ 390

  • x = 4: ∼ 510

  • (Fig. 3 Lane 9) 20

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.